Ann Saudi Med. 2024 Jul-Aug;44(4):264-271. doi: 10.5144/0256-4947.2024.264. Epub 2024 Aug 1.
ABSTRACT
INTRODUCTION: This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.
METHODS: The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.
RESULTS: Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, P<001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).
DISCUSSION: Platelet-rich plasma is an effective method of healing people with anal fistula.
PMID:39127896 | DOI:10.5144/0256-4947.2024.264
